RENOVIS INC 4
4 · RENOVIS INC · Filed Mar 17, 2006
Insider Transaction Report
Form 4
RENOVIS INCRNVS
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
- Sale
Common Stock
2006-03-16$23.38/sh−4,000$93,520→ 35,966 total
Footnotes (1)
- [F1]Disposition of securities made pursuant to a 10b5-1 plan adopted by Dr. Kelly on March 17, 2005.